ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $34,113,000 | -12.0% | 830,000 | 0.0% | 0.45% | +0.4% |
| Q1 2024 | $38,752,700 | +131.5% | 830,000 | +137.1% | 0.45% | +95.7% |
| Q4 2023 | $16,737,000 | -68.7% | 350,000 | -76.7% | 0.23% | -72.3% |
| Q3 2023 | $53,475,000 | +54.6% | 1,500,000 | +100.0% | 0.83% | +77.8% |
| Q2 2023 | $34,597,500 | +15.0% | 750,000 | 0.0% | 0.47% | +5.2% |
| Q1 2023 | $30,075,000 | -13.4% | 750,000 | 0.0% | 0.45% | -14.1% |
| Q4 2022 | $34,747,500 | +11.9% | 750,000 | 0.0% | 0.52% | -9.6% |
| Q3 2022 | $31,058,000 | -30.6% | 750,000 | 0.0% | 0.57% | -35.1% |
| Q2 2022 | $44,745,000 | +167.9% | 750,000 | +226.1% | 0.88% | +189.8% |
| Q1 2022 | $16,703,000 | – | 230,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 110,000 | $12,340,000 | 5.16% |
| Iguana Healthcare Management, LLC | 115,000 | $12,901,000 | 4.24% |
| WEATHERBIE CAPITAL, LLC | 206,559 | $23,172,000 | 2.72% |
| Cormorant Asset Management, LP | 109,500 | $12,284,000 | 1.47% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,111,566 | $124,695,000 | 1.25% |
| Visium Asset Management, LP | 629,934 | $70,665,000 | 1.06% |
| Rock Springs Capital Management LP | 105,500 | $11,835,000 | 0.90% |
| Cupps Capital Management, LLC | 53,272 | $5,976,000 | 0.84% |
| ROCKEFELLER FINANCIAL SERVICES INC | 289,907 | $32,521,000 | 0.63% |
| Lisanti Capital Growth, LLC | 4,385 | $492,000 | 0.52% |